麻豆女优

Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Health Care Helpline
    • 麻豆女优 Health News Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    • See All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • The Body Shops
    • Broken Rehab
    • Deadly Denials
    • Priced Out
    • Dead Zone
    • Diagnosis: Debt
    • Overpayment Outrage
    • Opioid Settlement Tracking
    • See All Special Reports
  • More Topics

    More Topics

    • Elections
    • Health Care Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health

  • Community Health Workers
  • Rural Health Payout
  • Measles Outbreaks
  • Doctors’ Liability Premiums
  • Florida鈥檚 KidCare

TRENDING TOPICS:

  • Community Health Workers
  • Rural Health Payout
  • Measles Outbreaks
  • Doctors' Liability Premiums
  • Florida鈥檚 KidCare

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Friday, Jul 29 2016

Full Issue

Alzheimer Drug Failure Deals Crushing Blow To Scientists Who Rail Over 35 Years Of Missteps

Researchers have approached a cure with the mindset that it was the expectation that amyloid plaques and tau tangles kill brain synapses and neurons, and despite clues suggesting otherwise, the field has been stuck on that for decades. A promising drug's failure has sparked anger and frustration by those who have been toiling for all that time.

In the wake of disappointing results this week for yet another experimental Alzheimer鈥檚 drug, scientists who have toiled for decades to understand the devastating disease expressed frustration and even anger that their field has not made more progress toward a cure. ... To a growing number of scientists, the problem isn鈥檛 that there鈥檚 been too little time to make meaningful progress against a hugely complicated disease that strikes an organ unrivaled for its complexity. It鈥檚 that the field has made many missteps, that its leaders stifled research that deviated from the dominant theory of what caused Alzheimer鈥檚, and that it was too easy to count as progress journal papers rather than advances that help patients. (Begley, 7/28)

In other public health news, a new organ donation technique offers hope to patients, experts caution against a new trend of injecting gas into the areas around the eye and a study puts a price tag on the world's growing sedentary lifestyle聽鈥

The process is called perfusion... it means the delivery of oxygenated blood to the tissues of the body. Normally, they are inside. But donor kidneys have been perfused before transplant since the 1960s. Surgeons started experimenting with small numbers of other organs about a decade ago. Pumping blood or a synthetic solution through them for several hours allows time to run tests rather than discarding an organ because of the mere possibility of a problem. It also opens up all sorts of futuristic medical ideas. (Jablow, 7/29)

Forget all those creams that promise to reduce eye puffiness. A new beauty trend makes your eyes swell up on purpose 鈥 with the goal of making you look less tired. Fans of the procedure, called carboxytherapy, can spend thousands of dollars to have carbon dioxide injected both above and below the eye, hoping to stimulate blood flow and erase dark circles. But experts caution there isn鈥檛 any evidence to back up the procedure. It鈥檚 likely not even targeting the real root of the skin blemishes. 鈥淚 would be very skeptical of its use for dark circles,鈥 said Dr. Molly Wanner, a cosmetic dermatologist at Massachusetts General Hospital. (Thielking, 7/29)

Obesity, heart disease, and even an early death are some of the risks of physical inactivity. But what if we could put a dollar amount on the financial burden of an increasingly sedentary world? Researchers from the University of Sydney in Australia attempted to do just that in the first study to estimate the global cost of physical inactivity. The results are startling. The report, published in The Lancet, found that physical inactivity cost the world $67.5 billion in direct and indirect costs in 2013. (Welch, 7/28)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Tuesday, April 28
  • Monday, April 27
  • Friday, April 24
  • Thursday, April 23
  • Wednesday, April 22
  • Tuesday, April 21
More Morning Briefings
RSS Feeds
  • Podcasts
  • Special Reports
  • Morning Briefing
  • About Us
  • Republish Our Content
  • Contact Us

Follow Us

  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

漏 2026 麻豆女优